Ipsen in talks with NICE over Cabometyx rejection

20th April 2017 Uncategorised 0

Ipsen says discussions with the National Institute for Health and Care Excellence are ongoing following a second rejection of Cabometyx for advanced renal cell carcinoma (RCC).

More: Ipsen in talks with NICE over Cabometyx rejection
Source: News